Biontech Se
Patents = 66
Trademarks = 38
Forward Citations = 47
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
265 inventors (with patents filed for the assignee):
BioNTech SE is a German biotechnology company that specializes in the development and manufacture of immunotherapies for the treatment of cancer and other diseases. Founded in 2008, BioNTech has emerged as a leading provider of innovative precision medicine for personalized cancer immunotherapy. The company combines cutting-edge technologies such as mRNA therapy and individualized neoepitope-targeting vaccines to develop novel treatment approaches. BioNTech is committed to revolutionizing the treatment of cancer and aims to achieve long-lasting, durable remissions for patients.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com